Evaluating feasibility and preliminary effects of a patient portal on empowerment of breast and lung cancer patients and survivors

Evaluating feasibility and preliminary effects of a patient portal on empowerment of breast and lung cancer patients and survivors - Patient portal: feasibility and effects

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON38681

Enrollment

320

Registered

2013-08-30

Start date

2013-04-01

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer and lung cancer

Interventions

Patients in the control groups will receive care as usual which includes access to a basic information website (VOM) without any interactive features. Patients in the intervention groups will be giv

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with a histologically confirmed breast cancer or non-small cell lung cancer who will be treated with curative-intent (including lung cancer patients receiving concurrent chemo- and radiation therapy).

Exclusion criteria

Exclusion criteria: -Significant cognitive impairment (such as post stroke, dementia etc.) -Presence of metastases

Design outcomes

Primary

Measure	Time frame
To study feasibility and acceptability as well as the effects of the patient portal on patient empowerment, physical activity, communication, dyspnea (lung cancer) and quality of life	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)